These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 139194)

  • 21. Rotational behavior produced by unilateral ventral noradrenergic bundle lesions: evidence for a noradrenergic-dopaminergic interaction in the brain.
    Płaźnik A; Puciłowski O; Kostowski W; Bidziński A; Hauptmann M
    Pharmacol Biochem Behav; 1982 Oct; 17(4):619-22. PubMed ID: 6184731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 23. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of harmine and brain lesions on apomorphine induced motor activity.
    Westermann KH; Funk K; Pawlowski L
    Pharmacol Biochem Behav; 1976 Jan; 4(1):1-6. PubMed ID: 131324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
    Yoon HH; Kim YH; Shin ES; Jeon SR
    J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic effects of apomorphine in rats with altered level of brain serotonin.
    Grabowska M; Michaluk J; Antkiewicz L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):517-26. PubMed ID: 126051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different behavioral responses to L-DOPA after anterolateral or posterolateral hypothalamic injections of 6-hydroxydopamine.
    Ervin GN; Fink JS; Young RC; Smith GP
    Brain Res; 1977 Sep; 132(3):507-20. PubMed ID: 303138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of serotonin neurotoxins on rotational behavior in the rat.
    Giambalvo CT; Snodgrass SR; Uretsky NJ
    Ann N Y Acad Sci; 1978 Jun; 305():524-31. PubMed ID: 309303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
    Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM
    J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings].
    Waddington JL; Crow TJ
    Br J Pharmacol; 1977 Mar; 59(3):465P-466P. PubMed ID: 300261
    [No Abstract]   [Full Text] [Related]  

  • 33. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):529-35. PubMed ID: 3936339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine and central serotonin neurons.
    Grabowska M; Antkiewicz L; Maj J; Michaluk J
    Pol J Pharmacol Pharm; 1973; 25(1):29-39. PubMed ID: 4272897
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonergic inhibition of catecholamine-induced behavioral arousal.
    Mabry PD; Campbell BA
    Brain Res; 1973 Jan; 49(2):381-91. PubMed ID: 4269051
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat brain L-3,4-dihydroxyphenylalanine and L-5-hydroxytryptophan decarboxylase activities: differential effect of 6-hydroxydopamine.
    Sims KL; Bloom FE
    Brain Res; 1973 Jan; 49(1):165-75. PubMed ID: 4540548
    [No Abstract]   [Full Text] [Related]  

  • 40. Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles.
    Donaldson IM; Dolphin AC; Jenner P; Pycock C; Marsden CD
    Brain Res; 1977 Dec; 138(3):487-509. PubMed ID: 597720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.